e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?
Sunyer J., Ulrik C. S.
Source:
Eur Respir J 2005; 25: 587-588
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sunyer J., Ulrik C. S.. Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?. Eur Respir J 2005; 25: 587-588
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Changes in physical activity and all-cause mortality in COPD
Source: Eur Respir J 2014; 44: 1199-1209
Year: 2014
Meta-analysis of FEV1 as a risk factor for all-cause mortality
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Relationship between mortality risk and health status in COPD
Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease
Year: 2009
The natural history of COPD without co-morbidities: predictors of long-term mortality
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
Tiotropium and the risk of cardiovascular events and all-cause mortality
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Changes in COPD-related morbidity and mortality after smoking cessation: a review
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Obesity, smoking and gender type as cardiovascular risk factors among COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 453s
Year: 2007
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Source: Eur Respir J 2008; 32: 844-853
Year: 2008
No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
Gender differences in mortality risks in relation to smoking in a long-term follow-up of the Malmö preventive project
Source: Eur Respir J 2003; 22: Suppl. 45, 111s
Year: 2003
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Age cohort mortality differences for respiratory and cardiovascular causes of death
Source: Eur Respir J 2001; 18: Suppl. 33, 151s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept